Axon Enterprise Prices $1 Billion in Zero-Coupon Convertible Senior Notes

Public safety technology provider Axon Enterprise, Inc. announced on Sept. 16 that it priced $1 billion in 0% convertible senior notes due Sept. 15, 2031, according to a report from Yahoo Finance (https://finance.yahoo.com/markets/stocks/articles/axon-enterprise-axon-prices-1b-194719659.html). Underwriters received an option to purchase up to an additional $150 million in notes to cover over-allotments. Settlement is scheduled for Sept. 18, subject to customary closing conditions.

Axon expects approximately $986 million in proceeds after deducting underwriting discounts and estimated offering expenses. The company allocated $99.9 million of that total toward capped-call transactions, leaving approximately $886.1 million for general corporate purposes, including potential investments and acquisitions. These figures do not account for potential proceeds if underwriters exercise the over-allotment option.

Because the senior unsecured notes carry a 0% regular interest coupon and do not accrete principal over time, the financing structure preserves cash relative to conventional interest-bearing debt. Retaining that cash allows the company to fund operational expansion or acquisitions ahead of revenue realization from new projects.

The initial conversion rate is set at 1.5336 shares per $1,000 principal amount, representing an initial conversion price of approximately $652.06 per share. Axon retains the flexibility to settle conversions in cash, common stock, or a combination of both, allowing management to balance liquidity demands against equity dilution.

To mitigate potential dilution upon conversion or offset cash payments above principal, Axon entered into capped-call transactions with an initial cap price of $1,049.94 per share, subject to adjustments. While these hedges provide a defined layer of protection for existing shareholders, the $99.9 million upfront cost lowers the immediate capital available for deployment, and protection remains bounded by the upper cap price.

The note agreement also provides holders with an early repurchase option on March 20, 2031, ahead of final maturity. Under specified conditions, Axon may pay for some or all of the principal using shares up to a defined ceiling, with any remainder payable in cash. The issuance follows a slight contraction in institutional positioning, with Insider Monkey data showing 53 hedge funds holding Axon shares at the end of the second quarter of 2026, down from 59 funds in the preceding quarter.